News
The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...
Oncology Clinical Trial Market Poised To Growth USD 85.5 Billion By 2035 With Thriving CAGR Of 3.84%
Oncology Clinical Trial Market Roche is actively conducting pivotal trials for novel therapies targeting advanced breast cancer, aiming to ...
After mid-day highlighted the issues posed by make-shift toilet blocks along Ram Mandir railway station road, WR removed all ...
Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...
Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...
The following personnel items are from the April 9 agenda of the Bettendorf Community School District. The School Board met ...
A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...
Evotec’s cost-cutting drive has reached its pipeline. The company axed around 30% of its asset portfolio and offloaded ...
6d
Zacks Investment Research on MSNBiotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More NewsIt was a busy week for the biotech sector as usual, with lots of regulatory and pipeline updates, before the first-quarter ...
Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced ...
According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results